172 related articles for article (PubMed ID: 2908604)
1. Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.
Sogani PC; Whitmore WF
Cancer Treat Res; 1988; 39():131-45. PubMed ID: 2908604
[TBL] [Abstract][Full Text] [Related]
2. [Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate].
Pavone-Macaluso M; Serretta V; Pavone C; Romano C; Daricello G
Arch Esp Urol; 1989; 42 Suppl 2():197-205. PubMed ID: 2534783
[TBL] [Abstract][Full Text] [Related]
3. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
[TBL] [Abstract][Full Text] [Related]
4. Advantages and disadvantages of pure antiandrogens and of antiandrogens of the cyproterone acetate-type in the treatment of prostatic cancer.
Habenicht UF; Schröder H; el Etreby MF; Neumann F
Prog Clin Biol Res; 1988; 260():63-75. PubMed ID: 2966407
[No Abstract] [Full Text] [Related]
5. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.
Migliari R; Muscas G; Murru M; Verdacchi T; De Benedetto G; De Angelis M
Arch Ital Urol Androl; 1999 Dec; 71(5):293-302. PubMed ID: 10673793
[TBL] [Abstract][Full Text] [Related]
6. Antiandrogenic agents as monotherapy in advanced prostatic carcinoma.
Soloway MS; Matzkin H
Cancer; 1993 Feb; 71(3 Suppl):1083-8. PubMed ID: 8428332
[TBL] [Abstract][Full Text] [Related]
7. Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.
Schröder FH
Prog Clin Biol Res; 1990; 359():93-103; discussion 105-7. PubMed ID: 2149460
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic substances in the management of prostatic cancer.
Schröder FH
Recent Results Cancer Res; 1990; 118():163-73. PubMed ID: 2146723
[TBL] [Abstract][Full Text] [Related]
9. Antiandrogenic drugs.
McLeod DG
Cancer; 1993 Feb; 71(3 Suppl):1046-9. PubMed ID: 8428326
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer.
Mahler C; Verhelst J; Denis L
Clin Pharmacokinet; 1998 May; 34(5):405-17. PubMed ID: 9592622
[TBL] [Abstract][Full Text] [Related]
11. Treatment of prostatic cancer. Newer forms of androgen deprivation.
Soloway MS
Postgrad Med; 1986 Jul; 80(1):249-52, 257-8. PubMed ID: 2941729
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Labrie C; Cusan L; Plante M; Lapointe S; Labrie F
J Steroid Biochem; 1987 Oct; 28(4):379-84. PubMed ID: 2444770
[TBL] [Abstract][Full Text] [Related]
13. Antiandrogens as monotherapy for prostate cancer.
Schröder FH
Eur Urol; 1998; 34 Suppl 3():12-7. PubMed ID: 9854190
[TBL] [Abstract][Full Text] [Related]
14. [Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
Akakura K; Furuya Y; Ito H
Nihon Rinsho; 1998 Aug; 56(8):2124-8. PubMed ID: 9750520
[TBL] [Abstract][Full Text] [Related]
15. Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
Di Silverio F; Sciarra F; D'Eramo G
Eur Urol; 1990; 18(1):10-5. PubMed ID: 2144819
[TBL] [Abstract][Full Text] [Related]
16. Cancer of the prostate. Mechanisms of action of antiandrogens.
Habenicht UF; Neumann F; el Etreby MF
Acta Urol Belg; 1991; 59(4):1-10. PubMed ID: 1840231
[No Abstract] [Full Text] [Related]
17. The place and the results of monotherapy.
Bonnet P
Acta Urol Belg; 1998 May; 66(2):11-5. PubMed ID: 9633120
[No Abstract] [Full Text] [Related]
18. "Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
Furr BJ
Horm Res; 1989; 32 Suppl 1():69-76. PubMed ID: 2533159
[TBL] [Abstract][Full Text] [Related]
19. The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.
de Voogt HJ
Prostate Suppl; 1992; 4():91-5. PubMed ID: 1533452
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats.
el Etreby MF; Habenicht UF; Louton T; Nishino Y; Schröder HG
Prostate; 1987; 11(4):361-75. PubMed ID: 2960960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
